Announcements Trials
Browse Landscape

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Observational 2

Sponsor

Cancer Type

CNS 6Genitourinary 2Gastrointestinal 2Thoracic 1Other 1Endocrine 1Breast 1

Conditions

Prostatic Neoplasms 1106Carcinoma, Renal Cell 412Urinary Bladder Neoplasms 280Kidney Neoplasms 177Neoplasm Metastasis 134Neoplasms 132Carcinoma, Non-Small-Cell Lung 109Carcinoma, Transitional Cell 108Breast Neoplasms 94Melanoma 90Ovarian Neoplasms 70Lung Neoplasms 67Colorectal Neoplasms 58Pancreatic Neoplasms 49Sarcoma 48Wilms Tumor 41Uterine Cervical Neoplasms 37Head and Neck Neoplasms 37Stomach Neoplasms 36Testicular Neoplasms 33Non-Muscle Invasive Bladder Neoplasms 33Esophageal Neoplasms 33Squamous Cell Carcinoma of Head and Neck 31Neuroblastoma 30Lymphoma, Non-Hodgkin 29Colonic Neoplasms 28Small Cell Lung Carcinoma 27Carcinoma, Hepatocellular 27Urethral Neoplasms 25Triple Negative Breast Neoplasms 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Epilepsy × Genitourinary × Clear all
NCT01236053 2017-07-06

Cancer in Patients With Gabapentin (GPRD)

GlaxoSmithKline

Completed
2,323,608 enrolled 86 charts
BreastGastrointestinalGenitourinaryThoracic

Anus Neoplasms, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Renal Cell, Diabetes Mellitus, Epilepsy, Kidney Neoplasms, Lung Neoplasms, Neoplasms, Nervous System Neoplasms, Neuralgia, Pancreatic Neoplasms, Penile Neoplasms, Stomach Neoplasms, Pancreatitis, Chronic

NCT01138124 2017-05-30

Gabapentin and Risk of Pancreatic Cancer and Renal Cancer (GPRD)

GlaxoSmithKline

Completed
54,202 enrolled 21 charts
GastrointestinalGenitourinary

Carcinoma, Renal Cell, Diabetes Mellitus, Epilepsy, Hypertension, Kidney Neoplasms, Neuralgia, Pancreatic Neoplasms, Restless Legs Syndrome, Pancreatitis, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡